Molecular Partners Ag Is A Clinical Stage Biopharmaceutical Company Based In Schlierenswitzerlandfounded In 2004 As A Spin Off From The University Of Za Richthe Company Specializes In Developing Darpin Therapeuticsa Unique Class Of Small Proteins Designed To Address Unmet Medical Needs In Oncologyimmuno Oncologyophthalmologyand Infectious Diseases The Company S Core Offering Is Its Darpin Platformwhich Creates Multi Specific And Highly Stable Protein Therapeuticsthese Proteins Can Target Multiple Pathways Simultaneouslymaking Them Suitable For Complex Diseasesmolecular Partners Has Two Darpin Molecules In Clinical Development And A Broad Preclinical Pipeline Targeting Various Conditionsthe Company Collaborates With Industry Leaders Like Allergan And Amgen To Advance Its Therapeutic Candidatesemphasizing Partnerships With Pharmaceutical Companiesclinical Research Organizationsand Academic Institutionsmolecular Partners Is Committed To Transforming Lives Through Innovative Therapiesfocusing On Collaboration And Patient Centric Innovation
Bio International Convention 2025
United States
16 Jun 2025
2345
| Company Name | Molecular Partners Ag |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
